Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lannett Co. Inc (LCI)

Lannett Co. Inc (LCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 405,286
  • Shares Outstanding, K 40,327
  • Annual Sales, $ 655,410 K
  • Annual Income, $ -272,110 K
  • 60-Month Beta 2.12
  • Price/Sales 0.58
  • Price/Cash Flow 2.50
  • Price/Book 1.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.27
  • Number of Estimates 3
  • High Estimate 0.29
  • Low Estimate 0.23
  • Prior Year 0.86
  • Growth Rate Est. (year over year) -68.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.81 +24.84%
on 01/08/20
10.34 -5.71%
on 01/17/20
+0.61 (+6.67%)
since 12/17/19
3-Month
7.81 +24.84%
on 01/08/20
13.12 -25.69%
on 11/04/19
-2.20 (-18.41%)
since 10/17/19
52-Week
5.16 +89.14%
on 06/03/19
15.52 -37.18%
on 09/13/19
+2.26 (+30.17%)
since 01/17/19

Most Recent Stories

More News
SmarTrend Watching for Potential Pullback in Shares of Lannett Co Inc After 4.64% Gain

Lannett Co Inc (NYSE:LCI) traded in a range yesterday that spanned from a low of $8.37 to a high of $8.81. Yesterday, the shares gained 4.6%, which took the trading range above the 3-day high of $8.50...

LCI : 9.75 (-2.99%)
Lannett Announces FDA Approval Of NDA For Branded Anesthetic Product, Cocaine Hydrochloride Nasal Solution 4%

Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA), submitted under the 505(b)(2) regulatory pathway, for Cocaine...

LCI : 9.75 (-2.99%)
Lannett Co Inc Shares Down 23.7% Since SmarTrend's Sell Call (LCI)

SmarTrend identified a Downtrend for Lannett Co Inc (NYSE:LCI) on October 14th, 2019 at $10.80. In approximately 3 months, Lannett Co Inc has returned 23.70% as of today's recent price of $8.24.

LCI : 9.75 (-2.99%)
Lannett Launches Venlafaxine ER Tablets And Lidocaine Topical Solution 4%

Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced marketing Venlafaxine Extended Release (ER) Tablets, 150 mg and 225 mg, USP, and Lidocaine Topical Solution 4%. The estimated IQVIA...

LCI : 9.75 (-2.99%)
SmarTrend Watching for Potential Rebound in Shares of Lannett Co Inc After 2.53% Loss

Lannett Co Inc (NYSE:LCI) traded in a range yesterday that spanned from a low of $8.78 to a high of $9.16. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $9.00 on...

LCI : 9.75 (-2.99%)
Lannett Receives FDA Approvals For Two Dosage Strengths Of Butalbital, Acetaminophen And Caffeine Capsules

Lannett Company, Inc. (NYSE: LCI) today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Butalbital, Acetaminophen...

LCI : 9.75 (-2.99%)
Lannett (LCI) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Lannett (LCI) closed at $9.01, marking a -1.64% move from the previous day.

LCI : 9.75 (-2.99%)
Implied Volatility Surging for Lannett (LCI) Stock Options

Investors need to pay close attention to Lannett (LCI) stock based on the movements in the options market lately.

LCI : 9.75 (-2.99%)
Lannett To Commence Marketing Generic Adderall® XR

Lannett Company, Inc. (NYSE: LCI) today announced that it expects to commence marketing in the coming months a generic version of Adderall XR®, an extended-release mixed salt of a single entity Amphetamine...

LCI : 9.75 (-2.99%)
Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall XR(R)

NORTHVALE, NJ / ACCESSWIRE / December 12, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing its own generic products, partnered generic...

LCI : 9.75 (-2.99%)
ELTP : 0.1011 (-1.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade LCI with:

Business Summary

Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable...

See More

Key Turning Points

2nd Resistance Point 10.68
1st Resistance Point 10.22
Last Price 9.75
1st Support Level 9.41
2nd Support Level 9.06

See More

52-Week High 15.52
Fibonacci 61.8% 11.56
Fibonacci 50% 10.34
Last Price 9.75
Fibonacci 38.2% 9.11
52-Week Low 5.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar